BACKGROUND: A number of community-based studies on the prevalence of PD have been conducted worldwide, but they are often extremely costly and time consuming. OBJECTIVE: To assess the prevalence of PD and parkinsonism for the population aged between 60 and 85 years in South Tyrol, Northern Italy, using a novel population-based three-stage ascertainment method. METHODS: Seven hundred fifty persons aged 60 to 85 years from South Tyrol received a validated screening mail questionnaire for parkinsonism. In the second stage of the ascertainment method, trained primary care physicians (PCP) identified all persons with possible parkinsonism among those screened positive. In the third stage, movement disorders specialists excluded or confirmed the diagnosis in all identified people. RESULTS: The response rate was 87.6%. The prevalence rate per 100 population over 65 years of age was 1.5 (95% CI 0.6 to 2.3) for PD and 2.2 (95% CI 1.2 to 3.3) for parkinsonism after having been adjusted to the 1991 European standard population. Overall, 78% (95% CI 59 to 96%) of patients with parkinsonism were newly detected through the survey. CONCLUSIONS: The prevalence of PD and parkinsonism in people aged over 65 in South Tyrol was similar to that observed in door-to-door surveys in other European countries. The novel three-stage case ascertainment method employed proved a useful tool to substitute for expensive door-to-door surveys for prevalence studies of parkinsonism, detecting a high number of undiagnosed cases, particularly in geographically remote areas.
BACKGROUND: A number of community-based studies on the prevalence of PD have been conducted worldwide, but they are often extremely costly and time consuming. OBJECTIVE: To assess the prevalence of PD and parkinsonism for the population aged between 60 and 85 years in South Tyrol, Northern Italy, using a novel population-based three-stage ascertainment method. METHODS: Seven hundred fifty persons aged 60 to 85 years from South Tyrol received a validated screening mail questionnaire for parkinsonism. In the second stage of the ascertainment method, trained primary care physicians (PCP) identified all persons with possible parkinsonism among those screened positive. In the third stage, movement disorders specialists excluded or confirmed the diagnosis in all identified people. RESULTS: The response rate was 87.6%. The prevalence rate per 100 population over 65 years of age was 1.5 (95% CI 0.6 to 2.3) for PD and 2.2 (95% CI 1.2 to 3.3) for parkinsonism after having been adjusted to the 1991 European standard population. Overall, 78% (95% CI 59 to 96%) of patients with parkinsonism were newly detected through the survey. CONCLUSIONS: The prevalence of PD and parkinsonism in people aged over 65 in South Tyrol was similar to that observed in door-to-door surveys in other European countries. The novel three-stage case ascertainment method employed proved a useful tool to substitute for expensive door-to-door surveys for prevalence studies of parkinsonism, detecting a high number of undiagnosed cases, particularly in geographically remote areas.
Authors: Katerina Mensikova; Petr Kanovsky; Michaela Kaiserova; Lenka Mikulicova; Miroslav Vastik; Petr Hlustik; Petr Jugas; Josef Ovecka; Vladimír Janout Journal: Eur J Epidemiol Date: 2013-07-26 Impact factor: 8.082
Authors: Nabila Dahodwala; Jason Karlawish; Andrew Siderowf; John E Duda; David S Mandell Journal: Neuroepidemiology Date: 2011-04-20 Impact factor: 3.282
Authors: Nabila Dahodwala; Jason Karlawish; Judy A Shea; Cynthia Zubritsky; Matthew Stern; David S Mandell Journal: PLoS One Date: 2012-08-24 Impact factor: 3.240
Authors: Lianna S Ishihara; Kay-Tee Khaw; Robert Luben; Sheila Bingham; Ailsa Welch; Nicholas Day; Carol Brayne Journal: BMC Neurol Date: 2005-08-24 Impact factor: 2.474
Authors: John T O'Brien; Wolfgang H Oertel; Ian G McKeith; Donald G Grosset; Zuzana Walker; Klaus Tatsch; Eduardo Tolosa; Paul F Sherwin; Igor D Grachev Journal: BMJ Open Date: 2014-07-03 Impact factor: 2.692
Authors: Suliman Khan; Ghulam Nabi; Muhammad Naeem; Liaqat Ali; Peter A Silburn; George D Mellick Journal: Neuropsychiatr Dis Treat Date: 2016-06-21 Impact factor: 2.570